Germany's Stada Strengthens Central, Eastern European Focus With Brand, Generic Buys
This article was originally published in The Pink Sheet Daily
Executive Summary
Stada spends $537 million on Grünenthal's branded product portfolio in Central and Eastern Europe and Spirig's generics business in Switzerland.